1. Home
  2. JNJ
  3. JNJ News

Latest Johnson & Johnson (JNJ) News on September 18, 2025

J&J and Protagonist’s oral plaque psoriasis drug bests BMS’ Sotyktu
JNJ

Clinical Trials Arena

5 hours ago

J&J and Protagonist’s oral plaque psoriasis drug bests BMS’ Sotyktu

JNJ

MT Newswires

20 hours ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Bernstein Reiterates a Sell Rating on Genmab A/S (GMAB)
JNJ

Insider Monkey

a day ago

Bernstein Reiterates a Sell Rating on Genmab A/S (GMAB)

JNJ

MT Newswires

a day ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years
JNJ

Zacks

a day ago

GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years

Protagonist Therapeutics, Inc. (PTGX): A Bull Case Theory
JNJ

Insider Monkey

a day ago

Protagonist Therapeutics, Inc. (PTGX): A Bull Case Theory

JNJ

MT Newswires

a day ago

Top Midday Stories: Markets Await Fed Rate Decision; China Regulator Reportedly Bans Nvidia Chip Sales to Alibaba, ByteDance

LLY's $5B Virginia Plant Plan: Will U.S. Manufacturing Shift Pay Off?
JNJ

Zacks

a day ago

LLY's $5B Virginia Plant Plan: Will U.S. Manufacturing Shift Pay Off?

JNJ

MT Newswires

a day ago

Market Chatter: Pharmaceutical Firms Pledge $350 Billion US Investment Amid Tariff Threats

Icotrokinra shows superiority to deucravacitinib in first reported head-to-head trials reinforcing promise of novel targeted oral peptide for treatment of plaque psoriasis
JNJ

PR Newswire

a day ago

Icotrokinra shows superiority to deucravacitinib in first reported head-to-head trials reinforcing promise of novel targeted oral peptide for treatment of plaque psoriasis

GSK Says It Will Spend $30B on U.S. Manufacturing and R&D
JNJ

Barrons.com

2 days ago

GSK Says It Will Spend $30B on U.S. Manufacturing and R&D

Guggenheim Reiterates a Hold on Johnson & Johnson (JNJ)
JNJ

Insider Monkey

2 days ago

Guggenheim Reiterates a Hold on Johnson & Johnson (JNJ)

Wolfe Research Lifts PT for Johnson & Johnson (JNJ), Keeps Outperform Rating
JNJ

Insider Monkey

2 days ago

Wolfe Research Lifts PT for Johnson & Johnson (JNJ), Keeps Outperform Rating

Johnson & Johnson (JNJ)’s Dividend Legacy: How a Healthcare Giant Built a Record of Consistent Dividends
JNJ

Insider Monkey

2 days ago

Johnson & Johnson (JNJ)’s Dividend Legacy: How a Healthcare Giant Built a Record of Consistent Dividends

Insulet names new CFO; Dexcom CEO on leave
JNJ

MedTech Dive

2 days ago

Insulet names new CFO; Dexcom CEO on leave

JNJ

MT Newswires

2 days ago

Market Chatter: Johnson & Johnson Among Firms in Talks for Rights to Shanghai Henlius Experimental Cancer Drug

JNJ

MT Newswires

2 days ago

JPMorgan Adjusts Price Target on Johnson & Johnson to $195 From $185, Maintains Neutral Rating

JNJ

South China Morning Post

2 days ago

Fosun's Henlius in talks with Johnson & Johnson, Roche on cancer drug

ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?
JNJ

Zacks

3 days ago

ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?

Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting
JNJ

PR Newswire

3 days ago

Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting

If You'd Invested $1,000 in Johnson & Johnson (JNJ) Stock 5 Years Ago, Here's How Much You'd Have Today
JNJ

Motley Fool

3 days ago

If You'd Invested $1,000 in Johnson & Johnson (JNJ) Stock 5 Years Ago, Here's How Much You'd Have Today

Jim Cramer Says Procter & Gamble Stock is “Still Way Too High”
JNJ

Insider Monkey

5 days ago

Jim Cramer Says Procter & Gamble Stock is “Still Way Too High”

How Strong Is Johnson & Johnson’s Value After FDA Nod for New Drug in 2025?
JNJ

Simply Wall St.

5 days ago

How Strong Is Johnson & Johnson’s Value After FDA Nod for New Drug in 2025?

Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.
JNJ

Barrons.com

6 days ago

Prescription Drug Ads Face Big Changes. These Stocks Could Get Hurt the Most.

JNJ Seeks EU Approval for Oral Psoriasis Drug Icotrokinra
JNJ

Zacks

6 days ago

JNJ Seeks EU Approval for Oral Psoriasis Drug Icotrokinra

AbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock
JNJ

Zacks

6 days ago

AbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock

Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug?
JNJ

Zacks

6 days ago

Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug?

India's Vadilal Industries U.S. unit to make ice creams locally to cut imports
JNJ

Reuters

6 days ago

India's Vadilal Industries U.S. unit to make ice creams locally to cut imports

Medincell Announces the Appointment of Dr. Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon to Its Board of Directors
JNJ

Business Wire

6 days ago

Medincell Announces the Appointment of Dr. Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon to Its Board of Directors

Asia cohort of Phase 3 MARIPOSA study shows RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) achieved statistically significant and clinically meaningful improvement in overall survival versus osimertinib in EGFR-mutated non-small cell lung cancer
JNJ

PR Newswire

7 days ago

Asia cohort of Phase 3 MARIPOSA study shows RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) achieved statistically significant and clinically meaningful improvement in overall survival versus osimertinib in EGFR-mutated non-small cell lung cancer

Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing
JNJ

Zacks

7 days ago

Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing

Warren Buffett wouldn’t worry about cash if he retired with just $1M — here’s why and how to copy his strategy
JNJ

Moneywise

7 days ago

Warren Buffett wouldn’t worry about cash if he retired with just $1M — here’s why and how to copy his strategy

JNJ

MT Newswires

7 days ago

Protagonist Says Johnson & Johnson Submits Application to EMA for Plaque Psoriasis Treatment

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
JNJ

Zacks

7 days ago

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Johnson & Johnson seeks first European Medicines Agency approval for icotrokinra aiming to transform the plaque psoriasis treatment paradigm
JNJ

GlobeNewswire

7 days ago

Johnson & Johnson seeks first European Medicines Agency approval for icotrokinra aiming to transform the plaque psoriasis treatment paradigm

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novartis, Pfizer and Bayer
JNJ

Zacks

7 days ago

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novartis, Pfizer and Bayer

Trump’s Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales.
JNJ

Barrons.com

8 days ago

Trump’s Going After Prescription Drug Ads. What It Means for Pharmaceutical Sales.

Johnson & Johnson's FDA-Approved Bladder Cancer Drug Offers New Option For Patients Avoiding Surgery
JNJ

Benzinga

8 days ago

Johnson & Johnson's FDA-Approved Bladder Cancer Drug Offers New Option For Patients Avoiding Surgery

5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds
JNJ

Zacks

8 days ago

5 Large Drug Stocks to Watch Despite Industry & Macro Headwinds

J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum
JNJ

Zacks

8 days ago

J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum

The Zacks Analyst Blog Highlights Johnson & Johnson, SAP, Coca-Cola, Hamilton Beach and SIFCO Industries
JNJ

Zacks

8 days ago

The Zacks Analyst Blog Highlights Johnson & Johnson, SAP, Coca-Cola, Hamilton Beach and SIFCO Industries

MedtechWOMEN Announces Virginia L. Giddings as Winner of the 2025 Ferolyn Powell Award
JNJ

Business Wire

8 days ago

MedtechWOMEN Announces Virginia L. Giddings as Winner of the 2025 Ferolyn Powell Award

JNJ

MT Newswires

8 days ago

Trump Signs Memorandum to Crack Down on Misleading Direct-to-Consumer Drug Ads

J&J obtains FDA approval for gemcitabine intravesical system
JNJ

Medical Device Network

8 days ago

J&J obtains FDA approval for gemcitabine intravesical system

Pharma’s new boomtown? Why drugmakers are setting up shop in a small Swiss city.
JNJ

Pharma Voice

8 days ago

Pharma’s new boomtown? Why drugmakers are setting up shop in a small Swiss city.

Jim Cramer on Johnson & Johnson: “Their Core Pharma Business is Roaring”
JNJ

Insider Monkey

9 days ago

Jim Cramer on Johnson & Johnson: “Their Core Pharma Business is Roaring”

JNJ

MT Newswires

9 days ago

Johnson & Johnson's Inlexzo to Treat Bladder Cancer Receives FDA Approval

Tylenol maker’s stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a ‘major overreaction’
JNJ

Fortune

9 days ago

Tylenol maker’s stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a ‘major overreaction’

Top Stock Reports for Johnson & Johnson, SAP & Coca-Cola
JNJ

Zacks

9 days ago

Top Stock Reports for Johnson & Johnson, SAP & Coca-Cola

JNJ

Argus Research

10 days ago

Weekly Stock List

Take the Zacks Approach to Beat the Markets: Hecla Mining, GE Aerospace & Stride in Focus
JNJ

Zacks

10 days ago

Take the Zacks Approach to Beat the Markets: Hecla Mining, GE Aerospace & Stride in Focus

JNJ

MT Newswires

10 days ago

Johnson & Johnson Says Potential Non-Small Cell Lung Cancer Treatment Improves Overall Survival

JNJ

MT Newswires

10 days ago

Johnson & Johnson Insider Sold Shares Worth $10,040,883, According to a Recent SEC Filing

A Fresh Look at Johnson & Johnson (JNJ) Valuation Following Recent Outperformance
JNJ

Simply Wall St.

11 days ago

A Fresh Look at Johnson & Johnson (JNJ) Valuation Following Recent Outperformance

Data published in The New England Journal of Medicine demonstrate RYBREVANT®▼(amivantamab) plus LAZCLUZE®▼ (lazertinib) could re-set survival expectations in first-line EGFR-mutated advanced lung cancer
JNJ

GlobeNewswire

11 days ago

Data published in The New England Journal of Medicine demonstrate RYBREVANT®▼(amivantamab) plus LAZCLUZE®▼ (lazertinib) could re-set survival expectations in first-line EGFR-mutated advanced lung cancer

Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer
JNJ

PR Newswire

11 days ago

Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer

3 Stocks to Buy and Hold Forever
JNJ

Motley Fool

12 days ago

3 Stocks to Buy and Hold Forever

RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) reduces acquired resistance versus osimertinib in first-line EGFR-mutated advanced non-small cell lung cancer
JNJ

GlobeNewswire

12 days ago

RYBREVANT®▼ (amivantamab) plus LAZCLUZE®▼ (lazertinib) reduces acquired resistance versus osimertinib in first-line EGFR-mutated advanced non-small cell lung cancer

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer
JNJ

PR Newswire

12 days ago

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer

JNJ

Morningstar Research

13 days ago

Analyst Report: Kenvue Inc.

Kenvue Stock Tumbles on Report Kennedy Will Link Autism and Tylenol
JNJ

Barrons.com

13 days ago

Kenvue Stock Tumbles on Report Kennedy Will Link Autism and Tylenol

JNJ

Business Wire

13 days ago

Ronovo Surgical Closes Series D Financing

BDTX Stock Surges 51.1% in Six Months: Is There More Room for Growth?
JNJ

Zacks

13 days ago

BDTX Stock Surges 51.1% in Six Months: Is There More Room for Growth?

Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion
JNJ

GlobeNewswire

13 days ago

Acetaminophen Market Trends and Forecasts, 2023-2024 & 2025-2033 | Rising OTC Demand, Wider Access to Essential Medicines, and Growth in Combination Therapies Drive Expansion

Campbell’s Appoints Kelly L. Palumbo Senior Vice President, Controller and Chief Accounting Officer
JNJ

Business Wire

14 days ago

Campbell’s Appoints Kelly L. Palumbo Senior Vice President, Controller and Chief Accounting Officer

Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX?
JNJ

Zacks

14 days ago

Is the Recent Pipeline Progress on its NSCLC Drug Enough for BDTX?

Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?
JNJ

Zacks

14 days ago

Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?

Tissue Engineering and Regeneration Technology Global Market Report 2025 & 2026-2030 | Focus on ESG, Technological Advancements, and Competitive Landscape
JNJ

GlobeNewswire

14 days ago

Tissue Engineering and Regeneration Technology Global Market Report 2025 & 2026-2030 | Focus on ESG, Technological Advancements, and Competitive Landscape

Kardium receives FDA OK for pulsed field ablation system
JNJ

MedTech Dive

14 days ago

Kardium receives FDA OK for pulsed field ablation system

Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
JNJ

Motley Fool

14 days ago

Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?

Johnson & Johnson Launches First Daily Disposable Toric Contact Lens Designed to Deliver on the Specific Needs of Low and High Astigmatic Patients in United Kingdom and Ireland (UKI)
JNJ

GlobeNewswire

14 days ago

Johnson & Johnson Launches First Daily Disposable Toric Contact Lens Designed to Deliver on the Specific Needs of Low and High Astigmatic Patients in United Kingdom and Ireland (UKI)

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
JNJ

Business Wire

15 days ago

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

JNJ

MT Newswires

15 days ago

Wolfe Research Hikes Price Target on Johnson & Johnson to $195 From $175

Factbox-Global drugmakers rush to boost US presence as tariff threat looms
JNJ

Reuters

15 days ago

Factbox-Global drugmakers rush to boost US presence as tariff threat looms

J&J Gears Up for Some Key New Drug Approvals and Launches
JNJ

Zacks

15 days ago

J&J Gears Up for Some Key New Drug Approvals and Launches

3 medtech takeaways from ESC 2025
JNJ

MedTech Dive

15 days ago

3 medtech takeaways from ESC 2025

Why drugmakers may need to borrow from quantum theory to confront tariff and pricing threats
JNJ

Pharma Voice

15 days ago

Why drugmakers may need to borrow from quantum theory to confront tariff and pricing threats

Johnson & Johnson Scores With Heart Pump Breakthrough
JNJ

GuruFocus.com

16 days ago

Johnson & Johnson Scores With Heart Pump Breakthrough

Glaukos Builds Dual Growth Engines Amid Market Headwinds
JNJ

Zacks

16 days ago

Glaukos Builds Dual Growth Engines Amid Market Headwinds

Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales
JNJ

Zacks

16 days ago

Eli Lilly's New Drugs Beyond Mounjaro and Zepbound Boost Sales

Nicotine Gum Market Report 2025-2033 | Competitive Analysis of British American Tobacco, Cambrex, GlaxoSmithKline, ITC, Johnson & Johnson, Novartis, Perrigo, Pfizer, and Takeda
JNJ

GlobeNewswire

16 days ago

Nicotine Gum Market Report 2025-2033 | Competitive Analysis of British American Tobacco, Cambrex, GlaxoSmithKline, ITC, Johnson & Johnson, Novartis, Perrigo, Pfizer, and Takeda

Grand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer
JNJ

GlobeNewswire

16 days ago

Grand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer

J&J publishes new data from DanGer Shock randomized control trial
JNJ

TipRanks

16 days ago

J&J publishes new data from DanGer Shock randomized control trial

JNJ

MT Newswires

16 days ago

Johnson & Johnson Says Varipure Showed 'Strong' Safety Outcomes in Pulsed Field Ablation Procedures

Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress
JNJ

PR Newswire

16 days ago

Johnson & Johnson Unveils Results from the VARIPURE Substudy of SECURE, a Real-World Study on VARIPULSE™ Platform, at 2025 European Society of Cardiology (ESC) Congress

Innovative Health Prevails in Lawsuit Against J&J's Biosense Webster for Restraint of Trade
JNJ

PR Newswire

16 days ago

Innovative Health Prevails in Lawsuit Against J&J's Biosense Webster for Restraint of Trade

UK Ligation Devices Market Analysis Report 2025-2033, with Profiles of Welfare Medical, Grena, Medtronic, Fannin, BioSpectrum, Teleflex, LocaMed, Johnson & Johnson, Boston Scientific, and more
JNJ

GlobeNewswire

16 days ago

UK Ligation Devices Market Analysis Report 2025-2033, with Profiles of Welfare Medical, Grena, Medtronic, Fannin, BioSpectrum, Teleflex, LocaMed, Johnson & Johnson, Boston Scientific, and more

Johnson & Johnson (JNJ)’s Carvykti Sales Skyrocket 100% Amid Specialty Medicine Growth
JNJ

Insider Monkey

16 days ago

Johnson & Johnson (JNJ)’s Carvykti Sales Skyrocket 100% Amid Specialty Medicine Growth

These 4 Dividend Stocks Are Money-Printing Machines
JNJ

Motley Fool

18 days ago

These 4 Dividend Stocks Are Money-Printing Machines

New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump
JNJ

PR Newswire

18 days ago

New Data from the DanGer Shock Randomized Control Trial, Published in The New England Journal of Medicine, Confirms the Long-Term Survival Benefit of the Impella CP Heart Pump

Large-cap biotech is a sector to watch for investors: Analysts
JNJ

Yahoo Finance

18 days ago

Large-cap biotech is a sector to watch for investors: Analysts

Will Johnson & Johnson's (JNJ) $2 Billion U.S. Manufacturing Move Reshape Its R&D Ambitions?
JNJ

Simply Wall St.

19 days ago

Will Johnson & Johnson's (JNJ) $2 Billion U.S. Manufacturing Move Reshape Its R&D Ambitions?

Earnings Season Highlights on Tariffs, Consumer Spending, and More
JNJ

Barrons.com

20 days ago

Earnings Season Highlights on Tariffs, Consumer Spending, and More

Johnson & Johnson Ends RA Combo After Mid-Stage Miss
JNJ

GuruFocus.com

20 days ago

Johnson & Johnson Ends RA Combo After Mid-Stage Miss

J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure
JNJ

Zacks

20 days ago

J&J Ends Imaavy Development in Rheumatoid Arthritis Post Study Failure

ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?
JNJ

Zacks

20 days ago

ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
JNJ

Zacks

20 days ago

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

JNJ

MT Newswires

20 days ago

Johnson & Johnson's Biosense Webster Unit Hit With Injunction for Antitrust Violations

JNJ

MT Newswires

20 days ago

Johnson & Johnson to Stop Clinical Development of Nipocalimab Combination Therapy for Rheumatoid Arthritis

Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Program
JNJ

Benzinga

20 days ago

Johnson & Johnson Ends Rheumatoid Arthritis Drug Combo Program

Share on Social Networks: